Small Move, Big Difference

With the MyoSure REACH device, you can reach for the far corners of the uterus with confidence and accuracy to get to the hard-to-reach pathology.


When compared with the current design, the MyoSure REACH device offers:

A shorter distance from the cutting blade to the distal tip—less than 1 mm—designed for easier access to polyps and fibroids up to 3 cm.

When resecting tissue simulated in the upper region of the uterine cavity, the MyoSure REACH device gets three times closer to the uterine model wall than the predecessor device—and removes 25% more tissue.*


*Based on internal bench testing that measured average relative height change of simulated 2 cm diameter tissue resected from a uterine model by 11 surgeon users.

Image of MyoSure Manuel device requirements - 1l saline bag, myosure hysteroscope, inflow/outflow tubing

This device allows you to REACH with confidence and may offer the added benefits of:

  • Complete resection of benign lesions may decrease likelihood of symptom recurrence.1
  • Easier access to hard-to-reach pathology can help to improve operative efficiency.
  1. Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2001;80(12):1131.

The MyoSure® tissue removal system, consisting of the MyoSure tissue removal devices (LITE, REACH, XL) and MyoSure controller, is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps, and retained products of conception. The MyoSure MANUAL hysteroscopic tissue removal device is intended for intrauterine use by a trained gynecologist to hysteroscopically resect and remove tissue, including focal lesions such as endometrial polyps and retained products of conception. MyoSure products are not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies, or previously diagnosed uterine cancer.

For more details on risks and benefits of the MyoSure system, MyoSure MANUAL tissue removal device, MyoSure hysteroscope and the Aquilex® fluid control system, please consult their respective IFUs.